H. Lee Moffitt Cancer Center & Research Institute Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile

H. Lee Moffitt Cancer Center & Research Institute Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH66767D
  • |
  • Pages: 35
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

H Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider that concentrates on the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services such as surgical care, fertility preservation, radiation therapy, interventional radiology, rehabilitation services, chemotherapy, cardio-oncology, blood and bone marrow transplant, cancer survivorship clinic, tumor board, interventional pain management, supportive care medicine, survivorship program, clinical trials, and others. It treats various types of cancers such as anal cancer, bladder cancer, brain cancer, breast cancer, colorectal cancer, esophageal cancer, gallbladder cancer and gastrointestinal carcinoid tumor, among others. Moffitt is headquartered in Tampa, Florida, the US.

H. Lee Moffitt Cancer Center & Research Institute Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

H. Lee Moffitt Cancer Center & Research Institute Inc, Medical Devices Deals, 2011 to YTD 2017 9

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Vycellix Enters into Research Agreement with Moffitt Cancer Center 12

Lion Biotechnologies Enters into Research Agreement with H. Lee Moffitt Cancer Center and Research Institute 12

Incyte Enters into Agreement with Moffitt Cancer Center 13

Morphogenesis Enters into Agreement with Moffitt Cancer Center 14

Ignyta Enters into Research Agreement with Moffitt Cancer Center 15

HealthMyne Enters into Research Agreement with Moffitt Cancer Center 15

Lion Biotech Enters into Research Agreement with Lee Moffitt Cancer Center and Research Institute 16

Rosetta Genomics Enters into Co-Development Agreement with Moffitt Cancer Center 17

Moffitt Cancer Center Enters Into Agreement With Advinus For Target Cancer Therapies 17

Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 18

H. Lee Moffitt Cancer Forms Joint Venture With US Oncology Network 20

Licensing Agreements 21

Moffitt Cancer Center Enters into Licensing Agreement with Celgene 21

Moffitt Cancer Center Enters into Option for Licensing Agreement with Forma Therapeutics 21

Lion Biotech Enters into Licensing Agreement wih Moffitt Cancer Center 22

Viteava Pharma Enters Into Licensing Agreement For Intellectual Property Portfolio Of Analogs And Derivatives 23

Asset Transactions 25

Aptose Biosciences to Acquire Rights to Potent Multi-Targeting Epigenetic Inhibitors from Moffitt Cancer Center 25

H. Lee Moffitt Cancer Center & Research Institute Inc-Key Competitors 26

Key Employees 27

Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 30

Government and Public Interest 30

Jan 11, 2017: Moffitt researchers develop novel treatment to prevent graft-versus-host-disease 30

Jul 15, 2016: Moffitt Cancer Center Receives Two NCI Grants 31

Jul 08, 2016: Moffitt Researchers Find New Way to Control Genes Often Involved in Cancer Growth 32

May 13, 2016: Genetic biomarker may predict nerve pain side effects associated with prostate cancer treatment 33

Mar 17, 2016: Neutralizing a Tumor's Acidic Environment Improves Activity of Immune-Targeting Cancer Therapies, Says Moffitt Cancer Center Researchers 34

Appendix 35

Methodology 35

About GlobalData 35

Contact Us 35

Disclaimer 35

List of Figures

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

H. Lee Moffitt Cancer Center & Research Institute Inc, Medical Devices Deals, 2011 to YTD 2017 9

List of Tables

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Key Facts 1

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

H. Lee Moffitt Cancer Center & Research Institute Inc, Deals By Therapy Area, 2011 to YTD 2017 8

H. Lee Moffitt Cancer Center & Research Institute Inc, Medical Devices Deals, 2011 to YTD 2017 9

H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Vycellix Enters into Research Agreement with Moffitt Cancer Center 12

Lion Biotechnologies Enters into Research Agreement with H. Lee Moffitt Cancer Center and Research Institute 12

Incyte Enters into Agreement with Moffitt Cancer Center 13

Morphogenesis Enters into Agreement with Moffitt Cancer Center 14

Ignyta Enters into Research Agreement with Moffitt Cancer Center 15

HealthMyne Enters into Research Agreement with Moffitt Cancer Center 15

Lion Biotech Enters into Research Agreement with Lee Moffitt Cancer Center and Research Institute 16

Rosetta Genomics Enters into Co-Development Agreement with Moffitt Cancer Center 17

Moffitt Cancer Center Enters Into Agreement With Advinus For Target Cancer Therapies 17

Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 18

H. Lee Moffitt Cancer Forms Joint Venture With US Oncology Network 20

Moffitt Cancer Center Enters into Licensing Agreement with Celgene 21

Moffitt Cancer Center Enters into Option for Licensing Agreement with Forma Therapeutics 21

Lion Biotech Enters into Licensing Agreement wih Moffitt Cancer Center 22

Viteava Pharma Enters Into Licensing Agreement For Intellectual Property Portfolio Of Analogs And Derivatives 23

Aptose Biosciences to Acquire Rights to Potent Multi-Targeting Epigenetic Inhibitors from Moffitt Cancer Center 25

H. Lee Moffitt Cancer Center & Research Institute Inc, Key Competitors 26

H. Lee Moffitt Cancer Center & Research Institute Inc, Key Employees 27

H. Lee Moffitt Cancer Center & Research Institute Inc, Subsidiaries 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

H. Lee Moffitt Cancer Center & Research Institute Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16065
Site License
USD 500 INR 32130
Corporate User License
USD 750 INR 48195

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com